US 5,672,700 AGranted

Loracarbef isopropanolate

AssigneeEli Lilly and Company

InventorsWilliam C. Henning, Michael E. O'Dea

Life of this patent

Estimating the term…

Abstract

The invention is directed to the crystalline isopropyl alcohol solvate of loracarbef, and also is directed to a process for the preparation of the crystalline monohydrate form of the compound of formula (I) ##STR1## which includes exposing the crystalline isopropyl solvate form of the compound of formula (I) to a temperature of between about 50.degree. and 90.degree. C. and a relative humidity of between about 60 to about 100%.

Claims2

Dependent claims

A crystalline isopropanolate form of the compound of formula (I) ##STR5##

Dependencies are inferred from the claim text.

Facts

Application: 08/347,759Filed 1 Dec 1994 · division
Priority: 4 Jun 1993
Granted: 30 Sep 1997
Term ends: Not estimatedThe source records don’t support an estimate.

Classification5 codes

C07D 471/04
In which the condensed system contains two hetero rings: ortho-condensed systems
A61P 31/00
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
C07D 463/22
With the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond…
C07D
Heterocyclic compounds

Family

Serial72,204Parent of this division · filed 4 Jun 1993
US 5,399,686 AParent of this division
US 5,672,700 AThis patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results